About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
ASND
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Ascendis Pharma FY 2023 Earnings Preview
- Ascendis, Frazier launch new ophthalmology company called Eyconis
- Jefferies starts Ascendis at buy, cites TransCon PTH market potential
- FDA accepts Ascendis resubmission of TransCon PTH market application
- Ascendis Pharma signs license agreement with Teijin in Japan
- Ascendis receives EU approval for hypoparathyroidism drug
- Citi opens 30-day catalyst watch on Ascendi ahead of FDA feedback
- Ascendis resubmits FDA application for hypoparathyroidism drug
- Ascendis Pharma GAAP EPS of -€2.88 misses by €0.39, revenue of €48.03M misses by €2.76M
- Ascendis Pharma Q3 2023 Earnings Preview
- EMA advisors recommend many new meds at latest meeting
- Ascendis wins EU backing for hormone replacement therapy
- Ascendis Pharma GAAP EPS of -€2.16, revenue of €47.39M
- Ascendis Pharma added to Wedbush's best ideas list
- Ascendis' TransCon gets FDA rejection but company hopeful as no new trials requested
- Ascendis Pharma reports Q1 results
- Ascendis Pharma Q1 2023 Earnings Preview
- Ascendis downgraded at Credit Suisse on deficiencies in drug application
- Ascendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon application
- Ascendis Pharma GAAP EPS of -€10.40, revenue of €51.17M
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 | 95.14 | 94.25 |
95.32
|
91.51
|
1.23M | 2.14% | ||||
| Aug 9 | 93.15 | 98.36 |
98.79
|
92.79
|
624.41K | -5.84% | ||||
| Aug 8 | 98.93 | 95.28 |
100.04
|
94.96
|
1.41M | 4.24% | ||||
| Aug 5 | 94.91 | 90.07 |
95.29
|
88.90
|
1.15M | 3.67% | ||||
| Aug 4 | 91.55 | 89.49 |
92.77
|
89.05
|
495.73K | 2.90% | ||||
| Aug 3 | 88.97 | 86.96 |
89.98
|
86.82
|
197.89K | 2.42% | ||||
| Aug 2 | 86.87 | 83.92 |
87.71
|
83.92
|
320.19K | 3.38% | ||||
| Aug 1 | 84.03 | 85.08 |
87.11
|
83.61
|
164.80K | -1.75% | ||||
| Jul 29 | 85.53 | 86.89 |
87.88
|
84.84
|
239.43K | -0.82% | ||||
| Jul 28 | 86.24 | 89.28 |
89.98
|
85.25
|
207.58K | -2.96% | ||||
| Jul 27 | 88.87 | 87.75 |
89.18
|
84.94
|
247.81K | 1.48% | ||||
| Jul 26 | 87.57 | 86.30 |
88.50
|
85.05
|
345.01K | 0.63% | ||||
| Jul 25 | 87.02 | 89.07 |
89.07
|
85.10
|
303.47K | -1.68% | ||||
| Jul 22 | 88.51 | 90.14 |
90.53
|
88.09
|
311.78K | -1.75% | ||||
| Jul 21 | 90.09 | 90.04 |
91.29
|
89.58
|
190.79K | -0.18% | ||||
| Jul 20 | 90.25 | 88.32 |
91.04
|
86.94
|
402.89K | 2.63% | ||||
| Jul 19 | 87.94 | 87.18 |
88.02
|
85.50
|
156.48K | 2.85% | ||||
| Jul 18 | 85.50 | 85.86 |
88.57
|
85.17
|
681.46K | 0.20% | ||||
| Jul 15 | 85.33 | 86.34 |
86.34
|
82.70
|
862.28K | -0.28% | ||||
| Jul 14 | 85.57 | 87.48 |
88.32
|
85.21
|
162.80K | -3.39% | ||||
| Jul 13 | 88.57 | 89.33 |
92.42
|
87.76
|
321.89K | -1.65% | ||||
| Jul 12 | 90.06 | 91.28 |
92.65
|
87.71
|
283.56K | -0.78% | ||||
| Jul 11 | 90.77 | 93.22 |
93.22
|
90.52
|
241.16K | -3.03% | ||||